PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Clinical trials for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA trials appear
Sign up with your email to follow new studies for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on tough blood cancers in early trial
Disease control Recruiting nowThis early-phase trial tests a personalized cell therapy called CART123 for adults with certain blood cancers (like acute myeloid leukemia) that have not responded to standard treatments. Each patient's own immune cells are collected, modified to target the CD123 protein on cance…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New CART therapy offers hope for young leukemia patients with no other options
Disease control Recruiting nowThis early-phase trial tests whether a new type of CART cell therapy is safe and possible for children, teens, and young adults with leukemia that has come back or not responded to standard treatments. The study includes two different CART products based on the specific type of l…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
New combo therapy aims to boost leukemia remission with fewer side effects
Disease control Recruiting nowThis study tests a combination of low-dose chemotherapy and immune-targeted drugs in adults newly diagnosed with Ph-negative B-cell acute lymphoblastic leukemia. The goal is to see if this gentler approach can clear cancer cells from the bone marrow and improve long-term survival…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC
-
New hope for kids with tough cancers: TURALIO trial opens
Disease control Recruiting nowThis study tests a drug called TURALIO (pexidartinib) in people aged 3 to 35 whose leukemia or solid tumors have not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors or stop them from growing. Participants take the drug daily for u…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 03, 2026 12:02 UTC
-
Buddy up to get better: virtual movement therapy boosts Kids' recovery after leukemia
Symptom relief Recruiting nowThis study looks at whether a 12-week virtual exercise program with a buddy can improve movement skills and quality of life in children aged 5 to 12 who have finished treatment for acute lymphoblastic leukemia. Kids in the program will do exercises with a healthy friend online. R…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: NA • Sponsor: Comenius University • Aim: Symptom relief
Last updated Jun 12, 2026 12:06 UTC